COMPUGEN (Israel) Today

COMPUGEN is trading at 2032.00 as of the 22nd of September 2021, a -2.07 percent decrease since the beginning of the trading day. The stock's open price was 2075.0. Equity ratings for COMPUGEN are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of August 2021 and ending today, the 22nd of September 2021. Click here to learn more.
Valuation Profit Patterns
Check how we calculate scores

COMPUGEN Stock Profile

Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. COMPUGEN operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 68 people. more on COMPUGEN
COMPUGEN is not yet fully synchronised with the market data
COMPUGEN generates negative expected return over the last 90 days
COMPUGEN has high historical volatility and very poor performance
The company reported the revenue of 2 M. Net Loss for the year was (35.73 M) with profit before overhead, payroll, taxes, and interest of 1.94 M.
COMPUGEN has accumulated about 110.41 M in cash with (30.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32.
CEOAnat CohenDayag  (View All)
Thematic Classification
Currently Active Investing Idea (view all)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of COMPUGEN's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedOvervalued
COMPUGEN (CGEN) is traded on Tel Aviv Stock Exchange in Israel and employs 68 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 167.02 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate COMPUGEN's market, we take the total number of its shares issued and multiply it by COMPUGEN's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. COMPUGEN operates under Healthcare sector and is part of Biotechnology industry. The entity has 83.68 M outstanding shares. COMPUGEN has accumulated about 110.41 M in cash with (30.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32.
Check COMPUGEN Probability Of Bankruptcy

COMPUGEN Stock Price Odds Analysis

What are COMPUGEN's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of COMPUGEN jumping above the current price in 90 days from now is more than 93.0%. The COMPUGEN probability density function shows the probability of COMPUGEN stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon COMPUGEN has a beta of -0.2451 suggesting as returns on benchmark increase, returns on holding COMPUGEN are expected to decrease at a much lower rate. During the bear market, however, COMPUGEN is likely to outperform the market. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. COMPUGEN is significantly underperforming DOW.
 Odds Down 2032.0HorizonTargetOdds Up 2032.0 
6.68%90 days
Based on a normal probability distribution, the odds of COMPUGEN to move above the current price in 90 days from now is more than 93.0 (This COMPUGEN probability density function shows the probability of COMPUGEN Stock to fall within a particular range of prices over 90 days) .

COMPUGEN Historical Income Statement

COMPUGEN Income Statement is one of the three primary financial statements used for reporting COMPUGEN's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of COMPUGEN revenue and expense. COMPUGEN Income Statement primarily focuses on the company's revenues and expenses during a particular period.
COMPUGEN Direct Expenses is projected to decrease significantly based on the last few years of reporting. The past year's Direct Expenses was at 69,000. The current year Revenues is expected to grow to about 1.8 M, whereas Net Income is forecasted to decline to (32 M). View More Fundamentals

COMPUGEN Stock Against Markets

Picking the right benchmark for COMPUGEN stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in COMPUGEN stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for COMPUGEN is critical whether you are bullish or bearish towards COMPUGEN at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with COMPUGEN stock to make a market-neutral strategy. Peer analysis of COMPUGEN could also be used in its relative valuation, which is a method of valuing COMPUGEN by comparing valuation metrics with similar companies.

COMPUGEN Corporate Directors

COMPUGEN corporate directors refer to members of a COMPUGEN board of directors. The board of directors generally takes responsibility for the COMPUGEN's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of COMPUGEN's board members must vote for the resolution. The COMPUGEN board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Joshua Shemer - Independent External DirectorProfile
Michal Preminger - DirectorProfile
Dov Hershberg - DirectorProfile
Arie Ovadia - Independent External DirectorProfile
Continue to Trending Equities. Note that the COMPUGEN information on this page should be used as a complementary analysis to other COMPUGEN's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Tools for COMPUGEN Stock

When running COMPUGEN price analysis, check to measure COMPUGEN's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COMPUGEN is operating at the current time. Most of COMPUGEN's value examination focuses on studying past and present price action to predict the probability of COMPUGEN's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move COMPUGEN's price. Additionally, you may evaluate how the addition of COMPUGEN to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities